ETFdb Realtime Rating & Analyst Report for XBI
XBI is a passive ETF that seeks to replicate the S&P Biotechnology Select Industry Index. S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the U.S. common stocks listed on the NYSE, AMEX, NASDAQ National Market and NASDAQ Small Cap exchanges. The Biotech Index is an equal weighted market cap index.
| ETFdb Category | Expense Ratio | Inception Date | Issuer | Structure | YTD Return * |
|---|---|---|---|---|---|
| Health & Biotech Equities | 0.35% | 2006-01-31 | State Street | ETF | +23.52% |
* As of 05-24-2012
XBI Realtime Rating: By Metric
| Metric | Metric Realtime Rating | A+ Metric Rated ETF |
|---|---|---|
| Liquidity | A | XLV |
| Expenses | A- | XLV |
| Performance |  |
|
| Volatility | |
|
| Dividend | |
|
| Concentration | |
|
The first adjacent table gives investors an individual Realtime Rating for XBI on several different metrics, including liquidity, expenses, performance, volatility, dividend, and concentration of holdings. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities ETFdb Category with the highest Metric Realtime Rating for each individual field.
XBI Realtime Rating: Overall
| ETFdb Rating Type | Overall Rating | A+ Overall Rated ETF |
|---|---|---|
| Realtime Rating (Overall) | |
|
The second table shows the overall Realtime Rating for XBI, as well as the A+ Overall Rated ETF in XBI's Category. To view information on how the ETFdb Realtime Ratings work, click here.
ETFdb Analyst Report for XBI
XBI is one of a handful of biotech ETFs available, offering exposure to a corner of the market that can perform well during periods of consolidation and is capable of big jumps in the event of major drug approvals. XBI focuses on a narrow sector of the health care sector, and as such is probably too...
Pro Membership Required to Continue Reading
To view the entire ETFdb Realtime Rating, you must be an ETFdb Pro member. To see all that is included in the ETFdb Realtime Rating, see the free previews of ten of the most popular ETFs: SPY, GLD, VWO, EFA, EEM, IVV, QQQ, TIP, VTI, LQD . Please login or begin your 7-day free trial to continue reading. There are several benefits to becoming an ETFdb Pro member today:
Get valuable insight from our analysts in the ETFdb Category reports, with in-depth breakdown every ETF niche, large or small.- Get portfolio guidance on nearly every possible investor scenario and include detailed information on risk profiles, asset correlation, portfolio management, and more.
- Get access to our premium monthly newsletter ETF Edge.
- Gain access to premium research reports covering popular sectors of the ETF industry.
- Read in-depth monthly Q&A's with our Senior Analyst Michael Johnston.
- Use the ETFdb Pro Screener to screen ETFs according to your own customized parameters, then download the results in Microsoft Excel format.
- Get 100% access to the ETF Head-To-Head Comparison Tool, a resource that shows how more than 1,100 ETFs stack up against the competition in terms of performance, holdings, and technical strength.
Begin Your Free 7-Day Trial Now - or - Read more about ETFdb Pro
